Gyn Onc Model
Please note: The model was developed with a temporal validation on a set of 290 patients diagnosed and
treated in a single institution (gynecologic oncology department). Model performance indices were as follows:
sensitivity 96%, specificity 86%, PPV 87.3%, NPV 95.6%, AUC 0.977.
Important - the model was not independently validated yet.
Reference: Stukan M, Badocha M, Ratajczak K. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study. BMC Cancer 2019;19:564.
Open access at: https://doi.org/10.1186/s12885-019-5629-x
Important - the model was not independently validated yet.
Reference: Stukan M, Badocha M, Ratajczak K. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study. BMC Cancer 2019;19:564.
Open access at: https://doi.org/10.1186/s12885-019-5629-x